close

Clinical Trials

1 2 3 4 5 218
Number of results: 4353

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-09-10 sapacitabin and olaparib BRCA mutant breast cancer 1b-2 Cyclacel Pharmaceuticals (USA - NJ) Cancer - Oncology
2018-09-07 COM701 1 Compugen (Israel) Cancer - Oncology
2018-09-05 SB-913 (adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human iduronate 2-sulfatase (hIDS) gene) mucopolysaccharidosis type II (Hunter's syndrome) 1-2 Sangamo Therapeutics (USA - CA) Rare diseases - Genetic diseases
2018-09-05 Lenti-D™ childhood cerebral adrenoleukodystrophy (CCALD - X-linked adrenoleukodystrophy cerebral childhood) 2-3 Bluebird bio (USA - MA) Rare diseases - Genetic diseases - Hematological diseases
2018-09-05 flortaucipir F 18 (LY3303560) 3 Eli Lilly (USA - IN)
2018-09-05 MIN-102 ( hydroxypioglitazone -5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride) patients with the AMN (adrenomyeloneuropathy) phenotype of X-linked adrenoleukodystrophy (X-ALD) 2-3 Minoryx Therapeutics (Spain) Rare diseases - Genetic diseases
2018-09-05 LYS-SAF302 mucopolysaccharidosis type IIIA (Sanfilippo B syndrome) 2-3 Lysogene (France) Rare diseases - Genetic diseases
2018-09-04 BI-1206 and rituximab relapsed or refractory non-Hodgkin lymphoma (NHL) including mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma 1-2 BioInvent (Sweden) Cancer - Oncology
2018-09-03 BioInvent (Sweden) Cancer - Oncology - Technology - Services
2018-08-31 anifrolumab moderate-to-severe systemic lupus erythematosus (SLE) 3 AstraZeneca (UK) Autoimmune diseases
2018-08-30 domagrozumab -PF-06252616 Duchenne muscular dystrophy (DMD) 2 Pfizer (USA - NY) Genetic diseases - Neuromuscular diseases - Rare diseases
2018-08-29 aducanumab (BIIB037) Alzheimer's disease (AD) 1b Biogen (USA - MA) Neurodegenerative diseases
2018-08-28 elafibranor - GFT505 primary biliary cholangitis (PBC) 2 Genfit (France) Liver diseases - Hepatic diseases
2018-08-27 Xarelto® (rivaroxaban) patients with chronic heart failure (HF) and significant coronary artery disease (CAD)

3 Bayer HealthCare (Germany) Janssen Research & Development (J&J) (USA - NJ) Cardiovascular diseases
2018-08-24 stem cell-derived exosomes atopic dermatitis preclinical Exocobio (Republic of Korea) Autoimmune diseases - Dermatological diseases
2018-08-16 fasinumab moderate-to-severe osteoarthritis pain of the hip or knee 3 Regeneron Pharmaceuticals (USA - NY) Teva Pharmaceutical (Israel) Rheumatic diseases - Inflammatory diseases
2018-08-16 INO-5401, INO-9012 and atezolizumab bladder cancer 1-2a Inovio Pharmaceuticals (USA - PA) Roche (Switzerland) Cancer - Oncology
2018-08-16 CT-P16 (biosimilar version of bevacizumab - Avastin®) breast cancer 3 Celltrion Healthcare (South Korea) Cancer - Oncology
2018-08-16 EDIT-101 Leber congenital amaurosis type 10 (LCA10) 1 Editas Medicine (USA - MA) Rare diseases - Genetic diseases - Ophtalmological diseases
2018-08-15 cabotegravir and rilpivirine HIV-1 infection 3 ViiV Healthcare (UK - USA) Infectious diseases